share_log

ASLAN Pharma Q1 2024 GAAP EPADS $(1.29) Misses $(0.61) Estimate

Benzinga ·  May 9 19:51
ASLAN Pharma Q1 2024 GAAP EPADS $(1.29) Misses $(0.61) Estimate
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment